Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-21

You can only go off what they have disclosed and assumed some level of due diligence was undertaken before making such forecasts.

The net burn rate is helped with R&D refund and Q1 and falls off in Q2. Clearly P3 (Stage 1) set-up costs have coming into the equation for prior Qtr.

So the clock is ticking and PR has taken us all to the edge of the financial dilution cliff with his dogmatic approach to world wide synchronised trials, inability to gauge the commercial metrics of deals including taking too long to short list target partners. Its all in all a sh#t show BUT there were been plenty of early warnings that the team doesn't have the requisite experience to build and deliver on a focused (narrowly framed) strategy to market.